Yan Ouyang
No. 197 Ruijin Er Road
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Atlas of glomerular disease-specific genetic effects on blood transcriptome.
Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2026
Association of Roxadustat Versus Erythropoiesis-Stimulating Agents With Renal Outcomes in Non-Dialysis CKD: A Propensity-Matched Real-World Cohort Study.
Journal: Clinical therapeutics
Published: May 03, 2026
Expert opinion on facilitating intrafamily communication in rare diseases-Lessons from Fabry disease.
Journal: Genetics in medicine open
Published: September 16, 2025
A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease.
Journal: Orphanet journal of rare diseases
Published: January 15, 2025
Efficacy and safety of telitacicept in IgA nephropathy: real-world study outcomes.
Journal: Clinical kidney journal
Published: December 12, 2024
Finerenone in Primary IgA Nephropathy: A Matched Case-Control Study.
Journal: Kidney diseases (Basel, Switzerland)
Published: November 07, 2024
A Targeted-Release Formulation of Budesonide for the Treatment of IgA Nephropathy Patients With Severe Renal Impairment.
Journal: Kidney international reports
Published: August 10, 2024
Uromodulin and progression of IgA nephropathy.
Journal: Clinical kidney journal
Published: March 23, 2024
Effect of therapeutic erythrocytapheresis on outcomes and renal benefit in patients with high-altitude polycythemia: a real-world study.
Journal: Scientific reports
Published: March 17, 2024
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids.
Journal: Kidney diseases (Basel, Switzerland)
Published: October 17, 2023
Last Updated: 09/26/2026